手机咨询更便捷
扫码立即和HR沟通
工作内容:
1. 利用临床前肿瘤动物模型的药效数据和PK/PD数据建模,指导药效试验以及支持临床剂量的选择;
2. 总结分析临床相关文献,运用定量药理学软件,对PK、PD数据进行分析,建立PKPD以及群体PK研究;
3. 参与跨部门合作和讨论,探讨和解决临床药理相关问题,参与起草本部门的SOP和工作模板。
岗位要求:
1. 硕士及以上学历,临床药理或定量药理专业;
2. 有基本生物分析,体外代谢或者药物转运体试验经验;
3. 良好的沟通能力,英语书面及口语表达能力;
4. 每周工作2天及以上;
5. 优秀实习生有机会转正。
The R&D (Research and Development) team of Dizal Pharma was AstraZeneca Asia and Emerging Market Research Center. As one of AstraZeneca’s first four R&D centers across the world, it dedicated to analyze the potential scientific mechanism of those most common diseases in Asia and fulfill the particular medical needs of Asian patients. It was one of the few R&D centers established by transnational pharmacy enterprises in China which had the ability to actually research, develop and produce micro-molecular new drugs, the ability to develop produce new drugs independently and completely, and the first-class medical platform in the world.
迪哲医药,于2017年10月独立运营,是一家研发驱动型生物医药企业,致力于全球创新药物(First-in-class/ Best-in-class)探索、研发以及商业化。
迪哲医药的前身为阿斯利康亚洲及新兴市场创新研发中心,设立于中国上海,是阿斯利康全球四个研发中心之一(另三个中心分别位于英国剑桥、瑞典哥德堡、美国盖瑟斯堡);是国际一流、高产出的创新药研发机构,拥有全球领先的转化医学和新药分子设计与筛选技术平台;在恶性肿瘤、自身免疫性疾病、肾病等重大疾病的新药研究方面积累了丰富经验。